Christian B. Voigtlander Sells 1,962 Shares of ICU Medical, Inc. (NASDAQ:ICUI) Stock

ICU Medical, Inc. (NASDAQ:ICUI) COO Christian B. Voigtlander sold 1,962 shares of the business’s stock in a transaction on Monday, November 25th. The shares were sold at an average price of $169.08, for a total transaction of $331,734.96. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Christian B. Voigtlander also recently made the following trade(s):

• On Wednesday, November 27th, Christian B. Voigtlander sold 1,430 shares of ICU Medical stock. The shares were sold at an average price of $158.00, for a total transaction of $225,940.00.

ICU Medical Stock Up 1.3 %

ICUI stock opened at $159.75 on Thursday. The stock has a market capitalization of $3.91 billion, a P/E ratio of -34.96 and a beta of 0.66. The firm has a 50-day simple moving average of $175.61 and a 200-day simple moving average of $146.51. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. ICU Medical, Inc. has a 52 week low of $83.26 and a 52 week high of $196.26.

Institutional Trading of ICU Medical

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Allworth Financial LP increased its stake in shares of ICU Medical by 100.0% during the third quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock worth $36,000 after purchasing an additional 100 shares in the last quarter. Xponance Inc. increased its stake in shares of ICU Medical by 6.0% during the second quarter. Xponance Inc. now owns 1,977 shares of the medical instruments supplier’s stock worth $235,000 after purchasing an additional 112 shares in the last quarter. Equitable Trust Co. increased its stake in shares of ICU Medical by 2.2% during the third quarter. Equitable Trust Co. now owns 5,213 shares of the medical instruments supplier’s stock worth $950,000 after purchasing an additional 112 shares in the last quarter. CWM LLC increased its stake in shares of ICU Medical by 18.5% during the second quarter. CWM LLC now owns 767 shares of the medical instruments supplier’s stock worth $91,000 after purchasing an additional 120 shares in the last quarter. Finally, Hexagon Capital Partners LLC grew its stake in ICU Medical by 162.7% during the 3rd quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier’s stock valued at $36,000 after acquiring an additional 122 shares in the last quarter. Hedge funds and other institutional investors own 96.10% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on ICUI. StockNews.com upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a research report on Wednesday, November 20th. Raymond James lifted their price objective on shares of ICU Medical from $158.00 to $190.00 and gave the company an “outperform” rating in a report on Thursday, September 12th. Jefferies Financial Group began coverage on shares of ICU Medical in a report on Monday, October 14th. They issued a “hold” rating and a $183.00 price objective for the company. Needham & Company LLC reaffirmed a “hold” rating on shares of ICU Medical in a report on Wednesday, November 13th. Finally, KeyCorp lifted their price objective on shares of ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a report on Wednesday, November 13th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $173.00.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.